US Patent 11884630 Heterocyclic compounds and their uses

Is a

Patent

Patent attributes

Patent Applicant

Cytokinetics

Current Assignee

Cytokinetics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118846300

Patent Inventor Names

Mingda Bi0

Robert Kuehl0

Date of Patent

January 30, 2024

Patent Application Number

178060330

Date Filed

June 8, 2022

Patent Citations

‌

US Patent 8110595 Ureas and their use in the treatment of heart failure

‌

US Patent 7507735 Compounds, compositions and methods

‌

US Patent 7989455 Compounds, compositions and methods

‌

US Patent 8101617 Disubstituted ureas and uses thereof in treating heart failure

‌

US Patent 10035770 Compounds, compositions and methods

‌

US Patent 10385023 Compounds, compositions and methods

‌

US Patent 10421726 Heterocyclic compounds and their uses

‌

US Patent 10543215 Combination therapy of cardiac myosin activator and sinus node if current inhibitor

...

Patent Primary Examiner

CPC Code

Patent abstract

Provided are certain pharmaceutical formulations of omecamtiv mecarbil and methods for their preparation and use.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11884630 Heterocyclic compounds and their uses

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11884630 Heterocyclic compounds and their uses